Respiratory

Acute exacerbations significantly worsen survival in progressive pulmonary fibrosis, urging a need for targeted management strategies.

Asthma increases the risk of bronchiectasis, with sinusitis and eosinophilic inflammation acting as mediators, according to a new genetic study.

Nicotinamide riboside reduces airway inflammation and boosts NAD+ levels in COPD patients, study shows.

AI-powered urine biomarkers predict COPD exacerbations up to a week before symptoms, paving the way for early intervention.

Machine learning predicts occurrence and mortality of sepsis-associated ARDS with high accuracy, study reveals.

COVID-19 poses significantly higher risks for people with multiple long-term conditions, with increased rates of mortality and severe outcomes.

No difference in mortality found between indwelling pleural catheters and chemical pleurodesis for treating malignant pleural effusions.

Atomized indocyanine green inhalation enhances precision and recovery in paediatric lung surgeries, study finds.